Poly (Lactic-co-glycolic Acid) & Tocopheryl Polyethylene Glycol Succinate Nanoparticles for the Treatment of Different Brain Cancers

(E-pub Ahead of Print)

Author(s): Akhil Kumar, Sankha Bhattacharya*, Charan Singh, Vikas Sharma

Journal Name: Anti-Cancer Agents in Medicinal Chemistry
(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)

Become EABM
Become Reviewer
Call for Editor


Nanotechnology and material science developments emerge in the manufacturing of various novel modes of drug delivery, which have proven scientifically promising. Polymer nanoparticles have high stability, high specificity, high drug-carrying power, control release and potential to be used in various pathways. They are able to supply hydrophilic and hydrophobic molecules with medicines. In this review, we have discussed about the different types of brain tumour, different PLGA (poly lactic-co-glycolic acid) nanostructure, PLGA in brain tumour targeting, and the recent advancement of PLGA based nanoparticles. This review focused on the method of preparation of polymeric nanoparticles, the significance of EPR (enhanced permeability and retention) effect with PLGA, the significance of TPGS in cancer, and discussed the pharmaceutical application of PLGA nanoparticles. We expect these polymeric nanoparticles will be very successful and efficient for disease targeting in the future and new techniques will become.

Keywords: Poly lactic-co-glycolic acid, tocopheryl polyethylene glycol succinate, brain tumour, cancer, PLGA Nanoparticles, EPR Effect

Rights & PermissionsPrintExport Cite as

Article Details

(E-pub Ahead of Print)
DOI: 10.2174/1871520621666210204201347
Price: $95

Article Metrics

PDF: 111